Loading...

PFE PFIZER INC Business Restructuring 8-K Filing

PFZR

PF

PFIZER INC

(PFE)

Debt-Equity Swaps

Cost Realignment

Financial Results

Financial Guidance

Q3 Earnings Report

Results of Operations and F...

Modifications to Compensati...

Departure of Directors

Election of Directors

Cost Reduction Program

Results of Operations and F...

Annual Meeting of Shareholders

Results of Operations and F...

Mini-Tender Offer

Acquisition of Seagen Inc.

Completion of Merger

Regulation FD Disclosure

Commercial Operations Reorg...

Results of Operations and F...

Earnings Update

Results of Operations and F...

Restructuring and reorganis...

Public Offering of Notes

Merger Agreement

Results of Operations and F...

Annual Meeting of Shareholders

Merger Agreement

Relocation of Headquarters

Results of Operations and F...

External Links:

PFIZER INC (PFE) 2025 8-K

Show Summary

On April 29, 2025, Pfizer reported its Q1 2025 financial results and announced $1.2 billion in additional anticipated savings from a cost realignment program, aiming for total savings of $5.7 billion by 2027.

AI Assistant

PFIZER INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.